Skip to content

The Effect of "Audit and Feedback" (A&F) Interventions on Standardized Treatment for Chlamydia: A Cluster Randomized Trial (ATTEND Trial)

'Assessment and feedback' (A&F) intervention on the impact of standardised treatment of chlamydia in a cluster randomised trial protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086892
Enrollment
Unknown
Registered
2024-07-15
Start date
2024-07-16
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chlamydia infection

Interventions

"Audit and Feedback" Intervention Group:The appropriate metrics for standardized chlamydia care for physicians are collected regularly and feedback is provided according to the guidelines.
Control Group:Feedback reports not provided

Sponsors

Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 100 Years

Inclusion criteria

Inclusion criteria: In the study population, institutional access conditions included: dermatology (skin and venereal disease), urology, male or gynecology at all levels of medical institutions in the pilot areas of the Chlamydia Prevention and Control Program in Guangdong Province. The five pilot areas were Nanshan District in Shenzhen City, Xiangzhou District in Zhuhai City, Xinyi City in Maoming City, Puning City in Jieyang City, and Xinxing County in Yunfu City.

Exclusion criteria

Exclusion criteria: Patients whose prescriptions meet the following conditions will be excluded from the data analysis: 1.The age is less than 18 years old; 2.Pregnant or lactating women; 3. Those who are allergic to cephalosporin, penicillin or have contraindications to cephalosporin; 4. Those who are receiving antibiotics for other infections.

Design outcomes

Primary

MeasureTime frame
Is chlamydia treatment standardized;

Secondary

MeasureTime frame
Number of prescriptions per collection for chlamydia treatment using the 11 drugs indicated in the guidelines;Prescriptions for the 11 drugs indicated in the guidelines were used in each prescription collection and the correct dosage was utilized;

Countries

China

Contacts

Public ContactHuanyuan Luo

Dermatology Hospital of Southern Medical University

huanyuanluo33@gmail.com+86 182 1562 7985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026